These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83. Assessing the non-cancer risk for RDX (hexahydro-1,3,5-trinitro-1,3,5-triazine) using physiologically based pharmacokinetic (PBPK) modeling. Sweeney LM; Gut CP; Gargas ML; Reddy G; Williams LR; Johnson MS Regul Toxicol Pharmacol; 2012 Feb; 62(1):107-14. PubMed ID: 22197625 [TBL] [Abstract][Full Text] [Related]
84. Inhibition effect of 2,4,6-trinitrotoluene (TNT) on RDX degradation by rhodococcus strains isolated from contaminated soil and water. Gupta S; Siebner H; Ramanathan G; Ronen Z Environ Pollut; 2022 Oct; 311():120018. PubMed ID: 36002099 [TBL] [Abstract][Full Text] [Related]
85. Use of pressurized liquid extraction (PLE)/gas chromatography-electron capture detection (GC-ECD) for the determination of biodegradation intermediates of hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX) in soils. Zhang B; Pan X; Cobb GP; Anderson TA J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 824(1-2):277-82. PubMed ID: 16112625 [TBL] [Abstract][Full Text] [Related]
86. Altered thalamic GABAA-receptor subunit expression in the stargazer mouse model of absence epilepsy. Seo S; Leitch B Epilepsia; 2014 Feb; 55(2):224-32. PubMed ID: 24417662 [TBL] [Abstract][Full Text] [Related]
87. Reevaluation of a twenty-four-month chronic toxicity/carcinogenicity study of hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX) in the B6C3F1 hybrid mouse. Int J Toxicol; ; . PubMed ID: 16940009 [TBL] [Abstract][Full Text] [Related]